nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Budesonide—ulcerative colitis	0.153	0.257	CbGbCtD
Conivaptan—CYP3A4—Methylprednisolone—ulcerative colitis	0.0681	0.115	CbGbCtD
Conivaptan—CYP3A4—Nicotine—ulcerative colitis	0.0664	0.112	CbGbCtD
Conivaptan—CYP3A4—Cholecalciferol—ulcerative colitis	0.0595	0.1	CbGbCtD
Conivaptan—CYP3A4—Triamcinolone—ulcerative colitis	0.0516	0.0868	CbGbCtD
Conivaptan—CYP3A4—Betamethasone—ulcerative colitis	0.0443	0.0745	CbGbCtD
Conivaptan—CYP3A4—Prednisolone—ulcerative colitis	0.0437	0.0735	CbGbCtD
Conivaptan—CYP3A4—Hydrocortisone—ulcerative colitis	0.0414	0.0697	CbGbCtD
Conivaptan—CYP3A4—Prednisone—ulcerative colitis	0.0413	0.0694	CbGbCtD
Conivaptan—CYP3A4—Dexamethasone—ulcerative colitis	0.0258	0.0433	CbGbCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00513	0.0325	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00509	0.0323	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide GPCRs—CXCR1—ulcerative colitis	0.00499	0.0317	CbGpPWpGaD
Conivaptan—AVPR2—Peptide GPCRs—CXCR1—ulcerative colitis	0.00496	0.0314	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide GPCRs—CXCR2—ulcerative colitis	0.00391	0.0248	CbGpPWpGaD
Conivaptan—AVPR2—Peptide GPCRs—CXCR2—ulcerative colitis	0.00388	0.0246	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide GPCRs—CCR6—ulcerative colitis	0.00367	0.0233	CbGpPWpGaD
Conivaptan—AVPR2—Peptide GPCRs—CCR6—ulcerative colitis	0.00365	0.0231	CbGpPWpGaD
Conivaptan—AVPR2—Arf6 trafficking events—ADRB2—ulcerative colitis	0.0035	0.0222	CbGpPWpGaD
Conivaptan—Pharyngolaryngeal pain—Mesalazine—ulcerative colitis	0.00321	0.0133	CcSEcCtD
Conivaptan—Lomitapide—ABCB1—ulcerative colitis	0.0032	0.43	CrCbGaD
Conivaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—ADCY5—ulcerative colitis	0.00319	0.0202	CbGpPWpGaD
Conivaptan—Laryngeal pain—Mesalazine—ulcerative colitis	0.00318	0.0132	CcSEcCtD
Conivaptan—Atrial fibrillation—Nicotine—ulcerative colitis	0.00296	0.0123	CcSEcCtD
Conivaptan—Cardiac failure—Nicotine—ulcerative colitis	0.00288	0.012	CcSEcCtD
Conivaptan—Tolvaptan—ABCB1—ulcerative colitis	0.00285	0.383	CrCbGaD
Conivaptan—AVPR2—Aquaporin-mediated transport—ADCY5—ulcerative colitis	0.00278	0.0176	CbGpPWpGaD
Conivaptan—Candida infection—Budesonide—ulcerative colitis	0.00254	0.0106	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00235	0.0149	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00233	0.0148	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.00213	0.0135	CbGpPWpGaD
Conivaptan—AVPR2—Arf6 trafficking events—CDH1—ulcerative colitis	0.00211	0.0134	CbGpPWpGaD
Conivaptan—Candida infection—Mesalazine—ulcerative colitis	0.00207	0.0086	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00206	0.0131	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00205	0.013	CbGpPWpGaD
Conivaptan—Thirst—Budesonide—ulcerative colitis	0.00203	0.00845	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.00195	0.0124	CbGpPWpGaD
Conivaptan—Oedema peripheral—Nicotine—ulcerative colitis	0.00191	0.00796	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00184	0.0117	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00184	0.0117	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00183	0.0116	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00182	0.0116	CbGpPWpGaD
Conivaptan—Cardiac disorder—Nicotine—ulcerative colitis	0.0018	0.0075	CcSEcCtD
Conivaptan—Hypokalaemia—Budesonide—ulcerative colitis	0.00176	0.00732	CcSEcCtD
Conivaptan—Mediastinal disorder—Nicotine—ulcerative colitis	0.00175	0.00728	CcSEcCtD
Conivaptan—Malnutrition—Mercaptopurine—ulcerative colitis	0.00174	0.00726	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00173	0.011	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00172	0.0109	CbGpPWpGaD
Conivaptan—Mental disorder—Nicotine—ulcerative colitis	0.0017	0.00708	CcSEcCtD
Conivaptan—Erythema—Nicotine—ulcerative colitis	0.00169	0.00703	CcSEcCtD
Conivaptan—Atrial fibrillation—Mesalazine—ulcerative colitis	0.00166	0.0069	CcSEcCtD
Conivaptan—Thirst—Mesalazine—ulcerative colitis	0.00165	0.00687	CcSEcCtD
Conivaptan—Anaemia—Mercaptopurine—ulcerative colitis	0.00161	0.00671	CcSEcCtD
Conivaptan—AVPR2—G alpha (s) signalling events—ADRB2—ulcerative colitis	0.00161	0.0102	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00158	0.00999	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00156	0.00992	CbGpPWpGaD
Conivaptan—Pollakiuria—Budesonide—ulcerative colitis	0.00154	0.00642	CcSEcCtD
Conivaptan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.00154	0.00977	CbGpPWpGaD
Conivaptan—Infestation—Budesonide—ulcerative colitis	0.00149	0.0062	CcSEcCtD
Conivaptan—Infestation NOS—Budesonide—ulcerative colitis	0.00149	0.0062	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.00147	0.00614	CcSEcCtD
Conivaptan—Hypertension—Nicotine—ulcerative colitis	0.00146	0.00607	CcSEcCtD
Conivaptan—Urinary tract infection—Budesonide—ulcerative colitis	0.00145	0.00602	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00144	0.00913	CbGpPWpGaD
Conivaptan—Orthostatic hypotension—Mesalazine—ulcerative colitis	0.00144	0.00597	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00143	0.00906	CbGpPWpGaD
Conivaptan—Haematuria—Budesonide—ulcerative colitis	0.00142	0.00591	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00141	0.00895	CbGpPWpGaD
Conivaptan—Dry mouth—Nicotine—ulcerative colitis	0.00141	0.00586	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00139	0.00883	CbGpPWpGaD
Conivaptan—Atorvastatin—ABCB1—ulcerative colitis	0.00139	0.187	CrCbGaD
Conivaptan—Confusional state—Nicotine—ulcerative colitis	0.00139	0.00579	CcSEcCtD
Conivaptan—Candida infection—Triamcinolone—ulcerative colitis	0.00138	0.00576	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00138	0.00877	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00138	0.00877	CbGpPWpGaD
Conivaptan—Skin disorder—Mercaptopurine—ulcerative colitis	0.00138	0.00575	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00137	0.00871	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—ADCY5—ulcerative colitis	0.00137	0.00867	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00135	0.00858	CbGpPWpGaD
Conivaptan—Nervous system disorder—Nicotine—ulcerative colitis	0.00135	0.00563	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00134	0.00852	CbGpPWpGaD
Conivaptan—Pneumonia—Azathioprine—ulcerative colitis	0.00134	0.00557	CcSEcCtD
Conivaptan—Infestation NOS—Azathioprine—ulcerative colitis	0.00133	0.00553	CcSEcCtD
Conivaptan—Infestation—Azathioprine—ulcerative colitis	0.00133	0.00553	CcSEcCtD
Conivaptan—Urinary tract disorder—Budesonide—ulcerative colitis	0.00132	0.00549	CcSEcCtD
Conivaptan—Oedema peripheral—Budesonide—ulcerative colitis	0.00132	0.00548	CcSEcCtD
Conivaptan—Urethral disorder—Budesonide—ulcerative colitis	0.00131	0.00545	CcSEcCtD
Conivaptan—Hypotension—Nicotine—ulcerative colitis	0.00129	0.00536	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00126	0.008	CbGpPWpGaD
Conivaptan—Pollakiuria—Mesalazine—ulcerative colitis	0.00125	0.00522	CcSEcCtD
Conivaptan—Insomnia—Nicotine—ulcerative colitis	0.00125	0.00519	CcSEcCtD
Conivaptan—Cardiac disorder—Budesonide—ulcerative colitis	0.00124	0.00516	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00123	0.00782	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.00123	0.00511	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00122	0.00776	CbGpPWpGaD
Conivaptan—Pneumonia—Mesalazine—ulcerative colitis	0.00122	0.00507	CcSEcCtD
Conivaptan—Angiopathy—Budesonide—ulcerative colitis	0.00121	0.00505	CcSEcCtD
Conivaptan—Infestation—Mesalazine—ulcerative colitis	0.00121	0.00504	CcSEcCtD
Conivaptan—Infestation NOS—Mesalazine—ulcerative colitis	0.00121	0.00504	CcSEcCtD
Conivaptan—Mediastinal disorder—Budesonide—ulcerative colitis	0.0012	0.00501	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CXCR1—ulcerative colitis	0.0012	0.00761	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCR1—ulcerative colitis	0.00119	0.00755	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00119	0.00755	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.00119	0.00496	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00118	0.0075	CbGpPWpGaD
Conivaptan—Pain—Nicotine—ulcerative colitis	0.00118	0.00491	CcSEcCtD
Conivaptan—Constipation—Nicotine—ulcerative colitis	0.00118	0.00491	CcSEcCtD
Conivaptan—Urinary tract infection—Mesalazine—ulcerative colitis	0.00118	0.0049	CcSEcCtD
Conivaptan—Mental disorder—Budesonide—ulcerative colitis	0.00117	0.00487	CcSEcCtD
Conivaptan—Malnutrition—Budesonide—ulcerative colitis	0.00116	0.00484	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00116	0.00735	CbGpPWpGaD
Conivaptan—Haematuria—Mesalazine—ulcerative colitis	0.00115	0.00481	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00115	0.0073	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.00115	0.00729	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.00115	0.00729	CbGpPWpGaD
Conivaptan—Cardiac failure—Hydrocortisone—ulcerative colitis	0.00115	0.00477	CcSEcCtD
Conivaptan—Feeling abnormal—Nicotine—ulcerative colitis	0.00114	0.00473	CcSEcCtD
Conivaptan—Body temperature increased—Mercaptopurine—ulcerative colitis	0.00113	0.00468	CcSEcCtD
Conivaptan—Body temperature increased—Nicotine—ulcerative colitis	0.00109	0.00454	CcSEcCtD
Conivaptan—Cardiac failure—Methylprednisolone—ulcerative colitis	0.00108	0.00448	CcSEcCtD
Conivaptan—Mediastinal disorder—Azathioprine—ulcerative colitis	0.00108	0.00448	CcSEcCtD
Conivaptan—Anaemia—Budesonide—ulcerative colitis	0.00108	0.00448	CcSEcCtD
Conivaptan—Urinary tract disorder—Mesalazine—ulcerative colitis	0.00107	0.00447	CcSEcCtD
Conivaptan—Oedema peripheral—Mesalazine—ulcerative colitis	0.00107	0.00446	CcSEcCtD
Conivaptan—Urethral disorder—Mesalazine—ulcerative colitis	0.00107	0.00444	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCL20—ulcerative colitis	0.00105	0.00668	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL20—ulcerative colitis	0.00105	0.00663	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00102	0.00647	CbGpPWpGaD
Conivaptan—Hypokalaemia—Hydrocortisone—ulcerative colitis	0.00102	0.00423	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00101	0.00643	CbGpPWpGaD
Conivaptan—Cardiac disorder—Mesalazine—ulcerative colitis	0.00101	0.0042	CcSEcCtD
Conivaptan—Hypertension—Budesonide—ulcerative colitis	0.001	0.00418	CcSEcCtD
Conivaptan—Sepsis—Prednisone—ulcerative colitis	0.000994	0.00414	CcSEcCtD
Conivaptan—Angiopathy—Mesalazine—ulcerative colitis	0.000986	0.00411	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000984	0.00409	CcSEcCtD
Conivaptan—Mediastinal disorder—Mesalazine—ulcerative colitis	0.00098	0.00408	CcSEcCtD
Conivaptan—Cardiac failure—Dexamethasone—ulcerative colitis	0.000978	0.00407	CcSEcCtD
Conivaptan—Cardiac failure—Betamethasone—ulcerative colitis	0.000978	0.00407	CcSEcCtD
Conivaptan—Pruritus—Nicotine—ulcerative colitis	0.000976	0.00406	CcSEcCtD
Conivaptan—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000974	0.00405	CcSEcCtD
Conivaptan—Dry mouth—Budesonide—ulcerative colitis	0.000969	0.00403	CcSEcCtD
Conivaptan—Anaemia—Azathioprine—ulcerative colitis	0.00096	0.004	CcSEcCtD
Conivaptan—Confusional state—Budesonide—ulcerative colitis	0.000958	0.00399	CcSEcCtD
Conivaptan—Mental disorder—Mesalazine—ulcerative colitis	0.000952	0.00396	CcSEcCtD
Conivaptan—Erythema—Mesalazine—ulcerative colitis	0.000946	0.00394	CcSEcCtD
Conivaptan—Diarrhoea—Nicotine—ulcerative colitis	0.000944	0.00393	CcSEcCtD
Conivaptan—Infection—Budesonide—ulcerative colitis	0.000944	0.00393	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CXCR2—ulcerative colitis	0.000939	0.00595	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000934	0.00593	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCR2—ulcerative colitis	0.000932	0.00591	CbGpPWpGaD
Conivaptan—Nervous system disorder—Budesonide—ulcerative colitis	0.000931	0.00388	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000928	0.00588	CbGpPWpGaD
Conivaptan—Skin disorder—Budesonide—ulcerative colitis	0.000923	0.00384	CcSEcCtD
Conivaptan—Vomiting—Mercaptopurine—ulcerative colitis	0.000905	0.00377	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000903	0.00572	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000896	0.00568	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCR6—ulcerative colitis	0.000883	0.0056	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000878	0.00366	CcSEcCtD
Conivaptan—Vomiting—Nicotine—ulcerative colitis	0.000877	0.00365	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CCR6—ulcerative colitis	0.000876	0.00556	CbGpPWpGaD
Conivaptan—Anaemia—Mesalazine—ulcerative colitis	0.000875	0.00364	CcSEcCtD
Conivaptan—Hypokalaemia—Betamethasone—ulcerative colitis	0.000869	0.00362	CcSEcCtD
Conivaptan—Hypokalaemia—Dexamethasone—ulcerative colitis	0.000869	0.00362	CcSEcCtD
Conivaptan—Headache—Nicotine—ulcerative colitis	0.000864	0.0036	CcSEcCtD
Conivaptan—Infestation—Hydrocortisone—ulcerative colitis	0.000861	0.00358	CcSEcCtD
Conivaptan—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000861	0.00358	CcSEcCtD
Conivaptan—Insomnia—Budesonide—ulcerative colitis	0.000859	0.00358	CcSEcCtD
Conivaptan—Cardiac failure—Prednisone—ulcerative colitis	0.000852	0.00355	CcSEcCtD
Conivaptan—Nausea—Mercaptopurine—ulcerative colitis	0.000845	0.00352	CcSEcCtD
Conivaptan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000843	0.00535	CbGpPWpGaD
Conivaptan—Infection—Azathioprine—ulcerative colitis	0.000842	0.00351	CcSEcCtD
Conivaptan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000841	0.00534	CbGpPWpGaD
Conivaptan—Skin disorder—Azathioprine—ulcerative colitis	0.000824	0.00343	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00082	0.00341	CcSEcCtD
Conivaptan—Nausea—Nicotine—ulcerative colitis	0.000819	0.00341	CcSEcCtD
Conivaptan—Hypertension—Mesalazine—ulcerative colitis	0.000817	0.0034	CcSEcCtD
Conivaptan—Constipation—Budesonide—ulcerative colitis	0.000812	0.00338	CcSEcCtD
Conivaptan—Pain—Budesonide—ulcerative colitis	0.000812	0.00338	CcSEcCtD
Conivaptan—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000809	0.00337	CcSEcCtD
Conivaptan—Infestation—Methylprednisolone—ulcerative colitis	0.000809	0.00337	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.0008	0.00333	CcSEcCtD
Conivaptan—Hypotension—Azathioprine—ulcerative colitis	0.000792	0.0033	CcSEcCtD
Conivaptan—Dry mouth—Mesalazine—ulcerative colitis	0.000788	0.00328	CcSEcCtD
Conivaptan—Feeling abnormal—Budesonide—ulcerative colitis	0.000783	0.00326	CcSEcCtD
Conivaptan—Confusional state—Mesalazine—ulcerative colitis	0.000779	0.00324	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—PTGER4—ulcerative colitis	0.000777	0.00493	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000773	0.0049	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—PTGER4—ulcerative colitis	0.000772	0.00489	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000768	0.00487	CbGpPWpGaD
Conivaptan—Infection—Mesalazine—ulcerative colitis	0.000767	0.00319	CcSEcCtD
Conivaptan—Nervous system disorder—Mesalazine—ulcerative colitis	0.000757	0.00315	CcSEcCtD
Conivaptan—Hypokalaemia—Prednisone—ulcerative colitis	0.000757	0.00315	CcSEcCtD
Conivaptan—Body temperature increased—Budesonide—ulcerative colitis	0.000751	0.00312	CcSEcCtD
Conivaptan—Skin disorder—Mesalazine—ulcerative colitis	0.00075	0.00312	CcSEcCtD
Conivaptan—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.000744	0.0031	CcSEcCtD
Conivaptan—Hyperglycaemia—Betamethasone—ulcerative colitis	0.000744	0.0031	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000732	0.00305	CcSEcCtD
Conivaptan—Hypotension—Mesalazine—ulcerative colitis	0.000722	0.003	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000716	0.00454	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—GHRL—ulcerative colitis	0.000712	0.00451	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—GHRL—ulcerative colitis	0.000706	0.00448	CbGpPWpGaD
Conivaptan—Feeling abnormal—Azathioprine—ulcerative colitis	0.000699	0.00291	CcSEcCtD
Conivaptan—Insomnia—Mesalazine—ulcerative colitis	0.000699	0.00291	CcSEcCtD
Conivaptan—Erythema—Prednisolone—ulcerative colitis	0.000689	0.00287	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000678	0.0043	CbGpPWpGaD
Conivaptan—Mental disorder—Hydrocortisone—ulcerative colitis	0.000677	0.00282	CcSEcCtD
Conivaptan—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000674	0.00281	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000673	0.00427	CbGpPWpGaD
Conivaptan—Erythema—Hydrocortisone—ulcerative colitis	0.000673	0.0028	CcSEcCtD
Conivaptan—Malnutrition—Hydrocortisone—ulcerative colitis	0.000673	0.0028	CcSEcCtD
Conivaptan—Pruritus—Budesonide—ulcerative colitis	0.000672	0.0028	CcSEcCtD
Conivaptan—Body temperature increased—Azathioprine—ulcerative colitis	0.00067	0.00279	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000667	0.00278	CcSEcCtD
Conivaptan—Constipation—Mesalazine—ulcerative colitis	0.000661	0.00275	CcSEcCtD
Conivaptan—Pain—Mesalazine—ulcerative colitis	0.000661	0.00275	CcSEcCtD
Conivaptan—Angiopathy—Methylprednisolone—ulcerative colitis	0.000659	0.00274	CcSEcCtD
Conivaptan—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000655	0.00272	CcSEcCtD
Conivaptan—Diarrhoea—Budesonide—ulcerative colitis	0.00065	0.0027	CcSEcCtD
Conivaptan—Hyperglycaemia—Prednisone—ulcerative colitis	0.000648	0.0027	CcSEcCtD
Conivaptan—Feeling abnormal—Mesalazine—ulcerative colitis	0.000637	0.00265	CcSEcCtD
Conivaptan—Mental disorder—Methylprednisolone—ulcerative colitis	0.000636	0.00265	CcSEcCtD
Conivaptan—Erythema—Triamcinolone—ulcerative colitis	0.000634	0.00264	CcSEcCtD
Conivaptan—Erythema—Methylprednisolone—ulcerative colitis	0.000632	0.00263	CcSEcCtD
Conivaptan—Malnutrition—Methylprednisolone—ulcerative colitis	0.000632	0.00263	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000616	0.0039	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCR1—ulcerative colitis	0.000611	0.00388	CbGpPWpGaD
Conivaptan—Body temperature increased—Mesalazine—ulcerative colitis	0.000611	0.00254	CcSEcCtD
Conivaptan—Vomiting—Budesonide—ulcerative colitis	0.000604	0.00251	CcSEcCtD
Conivaptan—Angiopathy—Betamethasone—ulcerative colitis	0.000599	0.00249	CcSEcCtD
Conivaptan—Angiopathy—Dexamethasone—ulcerative colitis	0.000599	0.00249	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000595	0.00377	CbGpPWpGaD
Conivaptan—Headache—Budesonide—ulcerative colitis	0.000595	0.00248	CcSEcCtD
Conivaptan—Hypertension—Prednisolone—ulcerative colitis	0.000595	0.00248	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CCL20—ulcerative colitis	0.000591	0.00375	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—ADRB2—ulcerative colitis	0.000589	0.00373	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—ADRB2—ulcerative colitis	0.000585	0.00371	CbGpPWpGaD
Conivaptan—Hypertension—Hydrocortisone—ulcerative colitis	0.000581	0.00242	CcSEcCtD
Conivaptan—Diarrhoea—Azathioprine—ulcerative colitis	0.00058	0.00241	CcSEcCtD
Conivaptan—Erythema—Betamethasone—ulcerative colitis	0.000575	0.00239	CcSEcCtD
Conivaptan—Erythema—Dexamethasone—ulcerative colitis	0.000575	0.00239	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000569	0.00237	CcSEcCtD
Conivaptan—Nausea—Budesonide—ulcerative colitis	0.000564	0.00235	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—GNA12—ulcerative colitis	0.00056	0.00355	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000557	0.00353	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GNA12—ulcerative colitis	0.000556	0.00352	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000553	0.00351	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000553	0.00351	CbGpPWpGaD
Conivaptan—Hypertension—Triamcinolone—ulcerative colitis	0.000547	0.00228	CcSEcCtD
Conivaptan—Pruritus—Mesalazine—ulcerative colitis	0.000546	0.00227	CcSEcCtD
Conivaptan—Hypertension—Methylprednisolone—ulcerative colitis	0.000546	0.00227	CcSEcCtD
Conivaptan—Infection—Hydrocortisone—ulcerative colitis	0.000546	0.00227	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCL20—ulcerative colitis	0.000541	0.00343	CbGpPWpGaD
Conivaptan—Vomiting—Azathioprine—ulcerative colitis	0.000539	0.00224	CcSEcCtD
Conivaptan—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000539	0.00224	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCL20—ulcerative colitis	0.000537	0.0034	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000535	0.00222	CcSEcCtD
Conivaptan—Skin disorder—Hydrocortisone—ulcerative colitis	0.000534	0.00222	CcSEcCtD
Conivaptan—Headache—Azathioprine—ulcerative colitis	0.000531	0.00221	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000531	0.00336	CbGpPWpGaD
Conivaptan—Diarrhoea—Mesalazine—ulcerative colitis	0.000528	0.0022	CcSEcCtD
Conivaptan—Dry mouth—Triamcinolone—ulcerative colitis	0.000528	0.0022	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000527	0.00334	CbGpPWpGaD
Conivaptan—Angiopathy—Prednisone—ulcerative colitis	0.000522	0.00217	CcSEcCtD
Conivaptan—Confusional state—Methylprednisolone—ulcerative colitis	0.00052	0.00217	CcSEcCtD
Conivaptan—Infection—Triamcinolone—ulcerative colitis	0.000514	0.00214	CcSEcCtD
Conivaptan—Hypotension—Hydrocortisone—ulcerative colitis	0.000513	0.00214	CcSEcCtD
Conivaptan—Infection—Methylprednisolone—ulcerative colitis	0.000513	0.00213	CcSEcCtD
Conivaptan—Insomnia—Prednisolone—ulcerative colitis	0.000509	0.00212	CcSEcCtD
Conivaptan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000508	0.00322	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GNA12—ulcerative colitis	0.000508	0.00322	CbGpPWpGaD
Conivaptan—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000506	0.00211	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—GNA12—ulcerative colitis	0.000505	0.0032	CbGpPWpGaD
Conivaptan—Mental disorder—Prednisone—ulcerative colitis	0.000504	0.0021	CcSEcCtD
Conivaptan—Nausea—Azathioprine—ulcerative colitis	0.000504	0.0021	CcSEcCtD
Conivaptan—Skin disorder—Methylprednisolone—ulcerative colitis	0.000501	0.00209	CcSEcCtD
Conivaptan—Malnutrition—Prednisone—ulcerative colitis	0.000501	0.00208	CcSEcCtD
Conivaptan—Erythema—Prednisone—ulcerative colitis	0.000501	0.00208	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR6—ulcerative colitis	0.000499	0.00316	CbGpPWpGaD
Conivaptan—Insomnia—Hydrocortisone—ulcerative colitis	0.000497	0.00207	CcSEcCtD
Conivaptan—Hypertension—Dexamethasone—ulcerative colitis	0.000496	0.00207	CcSEcCtD
Conivaptan—Hypertension—Betamethasone—ulcerative colitis	0.000496	0.00207	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CCR6—ulcerative colitis	0.000495	0.00314	CbGpPWpGaD
Conivaptan—Vomiting—Mesalazine—ulcerative colitis	0.000491	0.00204	CcSEcCtD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000484	0.00307	CbGpPWpGaD
Conivaptan—Headache—Mesalazine—ulcerative colitis	0.000484	0.00201	CcSEcCtD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000483	0.00306	CbGpPWpGaD
Conivaptan—Hypotension—Methylprednisolone—ulcerative colitis	0.000482	0.00201	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CXCR2—ulcerative colitis	0.000482	0.00306	CbGpPWpGaD
Conivaptan—Pain—Prednisolone—ulcerative colitis	0.000481	0.002	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CXCR2—ulcerative colitis	0.000478	0.00303	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000474	0.00197	CcSEcCtD
Conivaptan—Pain—Hydrocortisone—ulcerative colitis	0.00047	0.00195	CcSEcCtD
Conivaptan—Insomnia—Triamcinolone—ulcerative colitis	0.000468	0.00195	CcSEcCtD
Conivaptan—Insomnia—Methylprednisolone—ulcerative colitis	0.000467	0.00194	CcSEcCtD
Conivaptan—Infection—Betamethasone—ulcerative colitis	0.000466	0.00194	CcSEcCtD
Conivaptan—Infection—Dexamethasone—ulcerative colitis	0.000466	0.00194	CcSEcCtD
Conivaptan—Feeling abnormal—Prednisolone—ulcerative colitis	0.000463	0.00193	CcSEcCtD
Conivaptan—Anaemia—Prednisone—ulcerative colitis	0.000463	0.00193	CcSEcCtD
Conivaptan—Nervous system disorder—Betamethasone—ulcerative colitis	0.00046	0.00192	CcSEcCtD
Conivaptan—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00046	0.00192	CcSEcCtD
Conivaptan—Nausea—Mesalazine—ulcerative colitis	0.000459	0.00191	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCR6—ulcerative colitis	0.000453	0.00287	CbGpPWpGaD
Conivaptan—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000453	0.00188	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCR6—ulcerative colitis	0.00045	0.00285	CbGpPWpGaD
Conivaptan—Pain—Triamcinolone—ulcerative colitis	0.000442	0.00184	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—SEL1L—ulcerative colitis	0.000442	0.0028	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000439	0.00279	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SEL1L—ulcerative colitis	0.000439	0.00278	CbGpPWpGaD
Conivaptan—Hypotension—Dexamethasone—ulcerative colitis	0.000438	0.00182	CcSEcCtD
Conivaptan—Hypotension—Betamethasone—ulcerative colitis	0.000438	0.00182	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000436	0.00277	CbGpPWpGaD
Conivaptan—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000434	0.00181	CcSEcCtD
Conivaptan—Hypertension—Prednisone—ulcerative colitis	0.000432	0.0018	CcSEcCtD
Conivaptan—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000426	0.00177	CcSEcCtD
Conivaptan—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000425	0.00177	CcSEcCtD
Conivaptan—Insomnia—Dexamethasone—ulcerative colitis	0.000424	0.00177	CcSEcCtD
Conivaptan—Insomnia—Betamethasone—ulcerative colitis	0.000424	0.00177	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000423	0.00176	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000412	0.00261	CbGpPWpGaD
Conivaptan—Body temperature increased—Triamcinolone—ulcerative colitis	0.000409	0.0017	CcSEcCtD
Conivaptan—Infection—Prednisone—ulcerative colitis	0.000406	0.00169	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000405	0.00169	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000405	0.00169	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000402	0.00255	CbGpPWpGaD
Conivaptan—Pain—Dexamethasone—ulcerative colitis	0.000401	0.00167	CcSEcCtD
Conivaptan—Pain—Betamethasone—ulcerative colitis	0.000401	0.00167	CcSEcCtD
Conivaptan—Nervous system disorder—Prednisone—ulcerative colitis	0.000401	0.00167	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—GHRL—ulcerative colitis	0.000399	0.00253	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000399	0.00253	CbGpPWpGaD
Conivaptan—Skin disorder—Prednisone—ulcerative colitis	0.000397	0.00165	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—PTGER4—ulcerative colitis	0.000396	0.00251	CbGpPWpGaD
Conivaptan—Pruritus—Hydrocortisone—ulcerative colitis	0.000389	0.00162	CcSEcCtD
Conivaptan—Feeling abnormal—Betamethasone—ulcerative colitis	0.000387	0.00161	CcSEcCtD
Conivaptan—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000387	0.00161	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000384	0.00244	CbGpPWpGaD
Conivaptan—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000376	0.00156	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000374	0.00237	CbGpPWpGaD
Conivaptan—Body temperature increased—Dexamethasone—ulcerative colitis	0.000371	0.00154	CcSEcCtD
Conivaptan—Body temperature increased—Betamethasone—ulcerative colitis	0.000371	0.00154	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000371	0.00235	CbGpPWpGaD
Conivaptan—Insomnia—Prednisone—ulcerative colitis	0.00037	0.00154	CcSEcCtD
Conivaptan—Pruritus—Triamcinolone—ulcerative colitis	0.000366	0.00152	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—GHRL—ulcerative colitis	0.000365	0.00232	CbGpPWpGaD
Conivaptan—Pruritus—Methylprednisolone—ulcerative colitis	0.000365	0.00152	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CXCR1—ulcerative colitis	0.000364	0.00231	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GHRL—ulcerative colitis	0.000363	0.0023	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCR1—ulcerative colitis	0.000361	0.00229	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000356	0.00226	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CALM3—ulcerative colitis	0.000354	0.00224	CbGpPWpGaD
Conivaptan—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000353	0.00147	CcSEcCtD
Conivaptan—Headache—Prednisolone—ulcerative colitis	0.000352	0.00147	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CALM3—ulcerative colitis	0.000351	0.00223	CbGpPWpGaD
Conivaptan—Constipation—Prednisone—ulcerative colitis	0.000349	0.00145	CcSEcCtD
Conivaptan—Vomiting—Hydrocortisone—ulcerative colitis	0.000349	0.00145	CcSEcCtD
Conivaptan—Headache—Hydrocortisone—ulcerative colitis	0.000344	0.00143	CcSEcCtD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000337	0.00214	CbGpPWpGaD
Conivaptan—Feeling abnormal—Prednisone—ulcerative colitis	0.000337	0.0014	CcSEcCtD
Conivaptan—Nausea—Prednisolone—ulcerative colitis	0.000334	0.00139	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000333	0.00211	CbGpPWpGaD
Conivaptan—Pruritus—Betamethasone—ulcerative colitis	0.000332	0.00138	CcSEcCtD
Conivaptan—Pruritus—Dexamethasone—ulcerative colitis	0.000332	0.00138	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00033	0.0021	CbGpPWpGaD
Conivaptan—Vomiting—Triamcinolone—ulcerative colitis	0.000329	0.00137	CcSEcCtD
Conivaptan—Vomiting—Methylprednisolone—ulcerative colitis	0.000328	0.00137	CcSEcCtD
Conivaptan—Nausea—Hydrocortisone—ulcerative colitis	0.000326	0.00136	CcSEcCtD
Conivaptan—Headache—Triamcinolone—ulcerative colitis	0.000324	0.00135	CcSEcCtD
Conivaptan—Headache—Methylprednisolone—ulcerative colitis	0.000323	0.00135	CcSEcCtD
Conivaptan—Body temperature increased—Prednisone—ulcerative colitis	0.000323	0.00134	CcSEcCtD
Conivaptan—Diarrhoea—Betamethasone—ulcerative colitis	0.000321	0.00134	CcSEcCtD
Conivaptan—Diarrhoea—Dexamethasone—ulcerative colitis	0.000321	0.00134	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCL20—ulcerative colitis	0.000319	0.00203	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL20—ulcerative colitis	0.000317	0.00201	CbGpPWpGaD
Conivaptan—Nausea—Triamcinolone—ulcerative colitis	0.000307	0.00128	CcSEcCtD
Conivaptan—Nausea—Methylprednisolone—ulcerative colitis	0.000307	0.00128	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—ADRB2—ulcerative colitis	0.000302	0.00192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GNA12—ulcerative colitis	0.0003	0.0019	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRB2—ulcerative colitis	0.0003	0.0019	CbGpPWpGaD
Conivaptan—Vomiting—Betamethasone—ulcerative colitis	0.000298	0.00124	CcSEcCtD
Conivaptan—Vomiting—Dexamethasone—ulcerative colitis	0.000298	0.00124	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—GNA12—ulcerative colitis	0.000298	0.00189	CbGpPWpGaD
Conivaptan—Headache—Betamethasone—ulcerative colitis	0.000294	0.00122	CcSEcCtD
Conivaptan—Headache—Dexamethasone—ulcerative colitis	0.000294	0.00122	CcSEcCtD
Conivaptan—Pruritus—Prednisone—ulcerative colitis	0.000289	0.0012	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CXCR2—ulcerative colitis	0.000285	0.0018	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CXCL8—ulcerative colitis	0.000284	0.0018	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000283	0.0018	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCR2—ulcerative colitis	0.000283	0.00179	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000283	0.00179	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCL8—ulcerative colitis	0.000282	0.00179	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00028	0.00178	CbGpPWpGaD
Conivaptan—Diarrhoea—Prednisone—ulcerative colitis	0.00028	0.00116	CcSEcCtD
Conivaptan—Nausea—Betamethasone—ulcerative colitis	0.000279	0.00116	CcSEcCtD
Conivaptan—Nausea—Dexamethasone—ulcerative colitis	0.000279	0.00116	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCR6—ulcerative colitis	0.000268	0.0017	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR6—ulcerative colitis	0.000266	0.00168	CbGpPWpGaD
Conivaptan—Vomiting—Prednisone—ulcerative colitis	0.00026	0.00108	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000258	0.00163	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADCY5—ulcerative colitis	0.000257	0.00163	CbGpPWpGaD
Conivaptan—Headache—Prednisone—ulcerative colitis	0.000256	0.00107	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—ADCY5—ulcerative colitis	0.000255	0.00162	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAML2—ulcerative colitis	0.000254	0.00161	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAML2—ulcerative colitis	0.000252	0.0016	CbGpPWpGaD
Conivaptan—Nausea—Prednisone—ulcerative colitis	0.000243	0.00101	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PTGER4—ulcerative colitis	0.000236	0.00149	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTGER4—ulcerative colitis	0.000234	0.00148	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GHRL—ulcerative colitis	0.000216	0.00137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GHRL—ulcerative colitis	0.000214	0.00136	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CALM3—ulcerative colitis	0.000209	0.00132	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CALM3—ulcerative colitis	0.000207	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RIPK2—ulcerative colitis	0.000206	0.0013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RIPK2—ulcerative colitis	0.000204	0.0013	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.000189	0.0012	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB2—ulcerative colitis	0.000179	0.00113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB2—ulcerative colitis	0.000177	0.00112	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—JAK2—ulcerative colitis	0.000176	0.00112	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—JAK2—ulcerative colitis	0.000175	0.00111	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000161	0.00102	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—JAK2—ulcerative colitis	0.00016	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—ulcerative colitis	0.00016	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—JAK2—ulcerative colitis	0.000159	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2—ulcerative colitis	0.000154	0.000974	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2—ulcerative colitis	0.000153	0.000967	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADCY5—ulcerative colitis	0.000152	0.000961	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADCY5—ulcerative colitis	0.00015	0.000954	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—ulcerative colitis	0.000146	0.000926	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—ulcerative colitis	0.000145	0.000919	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2—ulcerative colitis	0.00014	0.000885	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2—ulcerative colitis	0.000139	0.000878	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JAK2—ulcerative colitis	9.45e-05	0.000599	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JAK2—ulcerative colitis	9.38e-05	0.000595	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RELA—ulcerative colitis	9.15e-05	0.00058	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RELA—ulcerative colitis	9.08e-05	0.000576	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—ulcerative colitis	8.62e-05	0.000547	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—ulcerative colitis	8.56e-05	0.000543	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2—ulcerative colitis	8.24e-05	0.000523	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—ulcerative colitis	8.2e-05	0.00052	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2—ulcerative colitis	8.18e-05	0.000519	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—ulcerative colitis	8.14e-05	0.000516	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—ulcerative colitis	7.8e-05	0.000495	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CHP1—ulcerative colitis	7.75e-05	0.000491	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—ulcerative colitis	7.74e-05	0.000491	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKB1—ulcerative colitis	7.72e-05	0.000489	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKB1—ulcerative colitis	7.66e-05	0.000486	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—ulcerative colitis	6.93e-05	0.00044	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—ulcerative colitis	6.88e-05	0.000437	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DLD—ulcerative colitis	6.69e-05	0.000424	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—ulcerative colitis	6.43e-05	0.000408	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—ulcerative colitis	6.38e-05	0.000405	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—ulcerative colitis	5.29e-05	0.000336	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—ulcerative colitis	5.25e-05	0.000333	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—ulcerative colitis	4.84e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—ulcerative colitis	4.81e-05	0.000305	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.23e-05	0.000205	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.91e-05	0.000185	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.26e-05	0.000144	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.11e-05	0.000134	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.57e-05	9.99e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—ulcerative colitis	1.42e-05	8.98e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.24e-05	7.86e-05	CbGpPWpGaD
